These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37188197)

  • 1. ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy.
    Yang X; Wang L; Jin X; Xu R; Yu Z; Li H; Lu H; An N
    Front Oncol; 2023; 13():1158104. PubMed ID: 37188197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
    Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
    JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma.
    Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Jiang H; Ming Wang J; Li B
    Radiol Oncol; 2020 Dec; 55(1):66-76. PubMed ID: 33885242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy.
    Yang H; Wang K; Li S; Li Y; Yuan L
    Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289
    [No Abstract]   [Full Text] [Related]  

  • 5. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
    Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z
    BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins.
    Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z
    Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
    Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
    BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinal radiotherapy after adjuvant chemotherapy for resected non-small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis.
    Harling L; Jayakumar S; Ashrafian H; Bille A; Toufektzian L; Smith D
    JTCVS Open; 2021 Mar; 5():121-130. PubMed ID: 36003173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
    Li D; Li W; Pang Y; Xu L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biomarker-based prediction model for risk of locoregional recurrence in pathologic stage IIIA-N2 non-small cell lung cancer.
    Jiang G; Huang J; Cui T; Lin X; Lin G
    Int J Clin Exp Pathol; 2020; 13(12):3060-3082. PubMed ID: 33425107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
    Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M
    Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer.
    Wang HH; Deng L; Wen QL; Zhang CZ; Zaorsky NG; Zhang BL; Chen J; Zeng XL; Cui YL; Shi YY; Hou HL; Wang W; Jiang B; Wang J; Pang QS; Zhao LJ; Yuan ZY; Wang P; Meng MB
    Oncotarget; 2017 Sep; 8(38):62998-63013. PubMed ID: 28968966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
    Deng Q; Wang H; Xiu W; Tian X; Gong Y
    Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
    Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
    Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
    Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
    Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy.
    Hui Z; Dai H; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Wang L
    Thorac Cancer; 2015 May; 6(3):346-53. PubMed ID: 26273382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of postoperative radiotherapy for IIIA‑N2 non‑small cell lung cancer after radical resection analysed using the propensity score‑matching method.
    Tian C; Liu G; Xu Y; Xia G; Zhang T; Huang J; Liu F; Li B
    Oncol Lett; 2023 May; 25(5):205. PubMed ID: 37123022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of postoperative radiotherapy on survival in patients with completely resected and pathologically confirmed stage N2 non-small-cell lung cancer: a systematic review and meta-analysis.
    Wang L; Chen W; Xu X; Chen W; Bao D; Zhang Y; Xu Y
    Ther Adv Chronic Dis; 2023; 14():20406223231195622. PubMed ID: 37720592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy's efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients.
    Zhang B; Zhao L; Yuan Z; Pang Q; Wang P
    Onco Targets Ther; 2016; 9():6161-6169. PubMed ID: 27785064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative radiotherapy option based on mediastinal lymph node reclassification for patients with pN2 non-small-cell lung cancer.
    Jin J; Xu Y; Hu X; Chen M; Fang M; Hang Q; Chen M
    Curr Oncol; 2020 Jun; 27(3):e283-e293. PubMed ID: 32669935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.